Epidemiological investigation on age-related macular degeneration in rural area of Shaanxi Province, China

International Journal of Ophthalmology

Volumn 5, Issue 6, 2005, Pages 1114-1121

  Bai, Zhi Lan ^a   Ren, Bai Chao ^a   Yang, Jian Gang ^a   He, Yuan ^a,b   Chen, Li ^a,c   Sun, Nai Xue ^a  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Department of Ophthalmology ^*  (China)

Author keywords

Age related macular degeneration; Epidemiology; Old people; Prevalence; Risk factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CAUCASIAN; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HIGH RISK POPULATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEGRO; OPHTHALMOSCOPY; PREVALENCE; RACE DIFFERENCE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; RETINA NEOVASCULARIZATION; RISK FACTOR; RURAL AREA; RURAL POPULATION; SEX DIFFERENCE; SMOKING;

EID: 31644433080     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Attebo K, Mitchell P, Smith W. Visual acuity and the cause of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology, 1996;103:357-364
2. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology, 1995; 102:1450-1460
3. Newland HS, Hiller JE, Casson RJ, Obermeber S. Prevalence and causes of blindness in the South Australian population aged 50 years and over. Ophthalmic Epidemiol, 1996;3:97-107
4. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci, 1995;36:182-191
5. Klein R, Klein BE, Lonton KL,. Prevalence age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology, 1992;99:933-943
6. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt JC, Martone JF, Royall RM, Witt KA, Ezrine S. Racial differences in the causes-specific prevalence of blindness in east Baltimore. N Engl J Med, 1991; 325: 1412-1417
7. Varmus H. Age-related macular degeneration: status of research, Washington, DC: Department of Health and Human Services, National Institute of Health, National Eye Institute, March, 1997
8. Klaver CC, Wolfs, RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol, 1998;116:653-658
9. Wang JJ, Foran S, Mitchell P. Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: The Blue Mountains Eye Study. Clin Experiment Ophthalmol, 2000;28:268-273
10. Weilh LM, VanNewkirk MR, McCarty CA, Taylor HR. Age-specific causes of bilateral visual impairment. Arch Ophthalmol, 2000;118:264-269
11. Munoz B, West SK, Rubin GS, Schein OD, Quigley HA, Bressler SB, Bandeen-Roche K. Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study. Arch Ophthalmol, 2000;118:819-825
12. Vingerling JR, Holman A, Grobbee DE, de Jong PT. Prevalence age-related maculopathy in the Rotterdam Study. Ophthalmology, 1995;102: 205-210
13. Klein R, Rowland ML, Harris MI. Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. Ophthalmology, 1995;102:371-381
14. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population: the national Health and Nutrition Examination Survey III. Ophthalmology, 1999; 106:1056-1065
15. Laatikainen L, Hirvela H. Prevalence and visual consequences of macular changes in a population aged 70 years and older. Acta Ophthalmol Scand Apr, 1995;73:105-110
16. VanNewkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR, Mccarty CA. The prevalence age-related maculopathy: the Visual Impairment Project. Ophthalmology, 2000;107:1593-1600
17. Friedman DS, Katz J, Bressler NM, Bahmani B, Tielsch JM. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology, 1999;106:1049-1055
18. Schachat AP, Hyman L, Leske MC, Connell AM, Wu SY. Barbados Eye Study Group. Features of age-related macular degeneration in a black population. Arch Ophthalmol, 1995;113:728-735
19. Moeller SM, Mares JA. Ethnic differences in diet and age-related maculopathies. Int Ophthalmol Clin, 2003;43:47-59
20. Klein R, Klein BE, Lonton KL, DeMets, DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol, 1993; 137:190-200
21. The Eye Disease Case-control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol, 1992;110:1701-1708
22. Vingerling JR, Klaver CC, Hofman A, de Jong PT. Epidemiology of age-related maculopathy. Epidemiol Rev, 1995;17:347-360
23. Hyman LG, Lilienfeld AM, Ferris FL 3rd, Fine SL. Senile macular degeneration: a case-control study. Am J Epidemiol, 1983;118:213-227
24. Vinding T, Appleyard M, Nyboe J, Jensen G. Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals. Arch Ophthalmol (Copenh), 1992;70:66-72
25. Klaver CC, Assink JJ, Vingerling JR, Hofman A, de Jong PT. Smoking is also associated with age-related macular degeneration in persons aged 85 years and older: The Rotterdam Study [letter]. Arch Ophthalmol, 1997;115-945
26. Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l'Age. Arch Ophthalmol, 1998;116:1031-1035
27. Klein R, Klein BE, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology, 1993;100:406-414
28. Goldberg J, Flowerdew G, Smith A, Brody JA. Factors associated with aged-related macular degeneration: An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol, 1988; 128: 700-710
29. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, Dawber TR. The Framingham Eye Study II. Association of ophthalmic pathology with single vatiable previously measured in the Framingham Health Study. Am J Epidemiol, 1977;106:33-41
30. Maltzman BA, Mulvihill MN, Greenbaum A. Senile macular defeneration and risk factors: a case study. Am J Ophthalmol, 1979;11:1197-1201
31. Ritter LA, Klein R, Klein BE. Mares-Perlman JA, Jensen SC. Alcohol use and aged-related maculopathy in the Beaver Dam Eye Study. Am J Ophthalmol, 1995;120:190-196
32. Moss SE, Klein R, Klein BEK, Jensen SC, Meuer SM. Alcohol consumption and the 5-year incidence of aged-related maculopathy. The Beaver Dam Eye Study. Ophthalmology, 1998;105:789-794
33. mith W, Mitchell P. Alcohol intake and aged-related maculopathy. Am J Ophthalmol, 1996;122:743-745
34. Obisesan TO, Hirsch R, Kosoko O, Carlson L, Parrott M. Moderate wine consumption is associated with decreased odds of developing aged-related macular degeneration in NHANES-1. JAGS, 1998;46:1-7
35. An international classification and grading system for age-related maculopathy and aged-related macular degeneration. The International AMD Epidemiological Study Group. Surv Ophthalmol, 1995;39:367-374
36. Evans JR. Risk factors for age-related macular. degeneration. Prog Retin Eye Res, 2001;20:227-253
37. He MG, Xu JJ, Wu KL, Li SZ. The prevalence age-related macular degeneration in Doumen County, Guangdong Province, Chin J Ocul Fundus Dis, 1998;114:122-124
38. Xuan MZ, Wang J, Zhao J, Jiang JK, Wu LL. The prevalence age-related macular degeneration. J Zhejiang Med Univ, 1994;23:78-82
39. Taylor HR, West S, Munoz B, Rosenthan FS, Bressler SB, Bressler NM. The long-term effects of visible light on the eye. Arch Opthalmol, 1992;110: 99-104
40. Ajani UA, Christen WG, Manson JE, Glynn RJ, Schaumberg D, Buring JE, Hennekens CH. A prospective study of alcohol Consumption and the risk of age-related macular degeneration. Ann Epidemiol, 1999;9:172-177